SCHEMBL13065735

SCHEMBL13065735

Cc1ccc(-c2c(C(=O)O)c3nc4ccccc4oc-3c(O)c2=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.48
HTT P42858 2/20 0.48
TSHR P16473 2/20 0.48
TP53 P04637 2/20 0.48
RET P07949 1/20 0.48
ALOX12 P18054 1/20 0.48
KDR P35968 1/20 0.48
POLB P06746 1/20 0.44
KDM4E B2RXH2 4/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
MAPT P10636 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
DHODH Q02127 6/20 0.41
GAA P10253 1/20 0.41
CRHBP P24387 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065731 0.92 DHODH (0.47) LMNAHTTTSHRTP53KDM4E
SCHEMBL13065738 0.90 HPGD (0.42) LMNATP53KDM4EMEN1KMT2A
SCHEMBL13065732 0.89 MAPK14 (0.45) LMNATP53ALOX12KDM4EMEN1
SCHEMBL13065729 0.88 KDM4E (0.51) LMNATP53KDM4EMEN1KMT2A
SCHEMBL16784744 0.88 PDE10A (0.40) LMNAHTTTSHRTP53POLB
SCHEMBL13065740 0.86 LMNA (0.39) LMNAHTTTSHRTP53POLB
SCHEMBL13065737 0.86 DHODH (0.39) LMNATP53KDM4EMEN1KMT2A
SCHEMBL13065739 0.86 ALDH1A1 (0.44) LMNAHTTTSHRTP53RET
SCHEMBL16784717 0.83 DHODH (0.39) LMNAHTTTSHRTP53RET
SCHEMBL13065733 0.81 KDM4E (0.53) LMNAHTTTSHRTP53ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 LMNA 4171/4885HTT 3584/4885TSHR 4704/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 LMNA 4171/4885HTT 3584/4885TSHR 4704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.